Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

UNITED KINGDOM: Studying the Role Genes Play in Treating TB




 

University of Liverpool (10.25.12) Aids Weekly Plus

The University of Liverpool, England, has been granted funding to investigate whether differences in genes determine how patients respond to anti-tuberculosis drugs in Sub-Saharan Africa. An international research team will investigate why some patients respond positively to anti-TB drug treatment, why the treatment fails in some, and why others experience toxicity. Professor Andrew Owen from the University of Liverpool’s Department of Molecular and Clinical Pharmacology, and part of the team, commented that there is a much greater understanding of genes that affect how individuals react and respond to drugs used in other diseases such as HIV than there is for TB. Researchers will study the genes of patients being treated with the four main anti-TB drugs, and with a new drug which is in development, using clinical trial sites in Benin, Senegal, and South Africa. The study will explore and determine genetic differences that affect the effectiveness and reaction to anti-TB drugs. It is funded through H3Africa research and capacity-building project and led by African scientists. The study is led by Dissou Affolabi of the National Hospital for Tuberculosis and Pulmonary Disease in Benin. Other partners are the National TB program in Senegal; the University Ignace Deen, Guinea; the University of Cape Town in South Africa; the Medical Research Council, South Africa; and the London School of Hygiene and Tropical Medicine.



 


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in October 25, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.